AKT1 and SELP polymorphisms predict the risk of developing cachexia in pancreatic cancer patients.
Pancreatic ductal adenocarcinoma (PDAC) patients have the highest risk of developing cachexia, which is a direct cause of reduced quality of life and shorter survival. Novel biomarkers to identify patients at risk of cachexia are needed and might have a substantial impact on clinical management. Her...
Guardado en:
Autores principales: | Abolfazl Avan, Amir Avan, Tessa Y S Le Large, Andrea Mambrini, Niccola Funel, Mina Maftouh, Majid Ghayour-Mobarhan, Maurizio Cantore, Ugo Boggi, Godefridus J Peters, Paola Pacetti, Elisa Giovannetti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bebe4ffa80444420a10125426b584cca |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
High-throughput microRNA (miRNAs) arrays unravel the prognostic role of MiR-211 in pancreatic cancer.
por: Elisa Giovannetti, et al.
Publicado: (2012) -
L-carnitine ameliorates the muscle wasting of cancer cachexia through the AKT/FOXO3a/MaFbx axis
por: Changpeng Wu, et al.
Publicado: (2021) -
Activation of the Complement System in Patients with Cancer Cachexia
por: Min Deng, et al.
Publicado: (2021) -
Amelioration of muscle wasting by gintonin in cancer cachexia
por: Yoseph Toni Wijaya, et al.
Publicado: (2021) -
Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
por: Joana M. O. Santos, et al.
Publicado: (2021)